Western University announces $3.5M endowment for new research chair in nephrology
On Friday, Western University announced a $3.5 million endowment that will go towards a new research chair in nephrology, the subspecialty of internal medicine that focuses on kidney disease.
The new chair has been named in honour of Dr. William Clark, a renowned nephrologist and professor emeritus at the Schulich School of Medicine & Dentistry. Dr. Clark was also named to the Order of Canada.
“It's very humbling,” said Dr. Clark. “My accomplishments are a result of working with very talented people.”
He has previously researched the long-term consequences of Canada’s worst E. coli contamination in Walkerton, Ont. back in 2000. During his time at Schulich, Clark focused his research on myeloma kidney disease, screening strategies for kidney disease, and the timing of initiation of dialysis.
Dr. Clark said researchers' number one priority is to prevent the progression of kidney disease and prevent the loss of kidney function.
According to the Kidney Foundation of Canada, four million Canadians are living with kidney disease, and more than 50,000 Canadians are being treated for kidney failure.
Symptoms are often silent in the early stages of kidney disease, which could lead to a significant loss in kidney function before symptoms appear.
To fund the research chair, Western matched funds raised through the London Health Sciences Foundation and The Kidney Foundation of Canada.
“The Clark Chair in Nephrology will contribute to developing better practices, policies, tools, and technology, all of which will translate into better treatments and patient care,” said Western President Alan Shepard.
The new research chair has not been chosen yet, however, they will play a key role in attracting and retaining research talent.
“Schulich Medicine’s nephrology program, in collaboration with London Health Sciences Centre, is already among the most comprehensive programs in Canada, treating thousands of patients across Ontario and on the leading edge of breakthroughs to prevent and treat kidney disease,” said Dean of Schulich Medicine & Dentistry Dr. John Yoo.
“Backed by a strong partnership, powered by permanently invested funds, this new research chair will fuel the next generation of promising treatments and therapies,” said Dr. Yoo.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
'Sophisticated' cyberattacks detected on B.C. government networks, premier says
There has been a "sophisticated" cybersecurity breach detected on B.C. government networks, Premier David Eby confirmed Wednesday evening.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
Rookie goalie Arturs Silovs to start for Canucks in Game 1 vs. Oilers
Rookie goalie Arturs Silovs will start in net for the Canucks as Vancouver kicks off a second-round series against the Edmonton Oilers Wednesday night.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.